August 2014

In this issue of Cardiology Review, we cover a wide variety of topics while saying goodbye to the summer of 2014.

A review of a trial of a self-contained leadless cardiac pacemaker

In this edition of Clinical Forum, we asked 3 Cardiology Review editorial board members to comment on the role of renal denervation following the publication of the SYMPLICITY HTN-3 trial results.

In their recent article published in the Journal of the American College of Cardiology, Vivek Y. Reddy, MD, and Jeffrey W. Olin, DO, noted "there are few areas in medicine that have gained as much prominence as quickly, or have been as widely dismissed as quickly, as catheter-based renal sympathetic denervation for the treatment of resistant hypertension.

The 74th Scientific Sessions of the American Diabetes Association (ADA) brought together more than 17,300 attendees from more than 121 countries. This year's program included 96 symposia, 50 oral abstract sessions, 10 interest group discussions, 18 meet-the-expert sessions, and 10 special lectures and addresses. Cardiology Review is covering 6 of the top sessions.

The optimal duration of DAPT following PCI with drug-eluting stents remains dubious.

The presence of coronary collateral circulation should be cardioprotective and beneficial, but the demonstration of such benefit has been more challenging.

This interesting study compared the effectiveness of human-led versus website-based counseling to reduce CHD risk.

The incidence of type 2 diabetes mellitus tripled in the last 20 years. What has that meant for rates of complications?

The use of various dietary supplements by patients will probably continue, so medical practitioners must be able to advise patients about potential harms and benefits.